EMBRACE Triplet Study

EMBRACE-III Triplet

Improving cervical cancer care through personalized radiation therapy

PROMISE, IMPACT, and REWIND studies for image-guided adaptive brachytherapy.

About Us Join Us

Clinical Studies

Participate in groundbreaking research that shapes the future of radiation therapy for cervical cancer.

REWIND

REWIND

Retrospective Real-World Interpretation of Data

Learn More Download Presentation (PDF) Access Database
IMPACT

IMPACT

CT-based Image Guided Adaptive Brachytherapy

Learn More Download Presentation (PDF) Access Database
PROMISE

PROMISE

Prospective Real-world MRI-based Treatment

Learn More Download Presentation (PDF) Database Coming Soon

Latest News

Stay updated with our latest announcements and research findings.

EMBRACE II Study Wins Donal Hollywood Award at ESTRO 2025
Announcements

EMBRACE II Study Wins Donal Hollywood Award at ESTRO 2025

Join Us!

Help advance cervical cancer treatment by participating in the EMBRACE-III Triplet Study. Together, we can improve patient care worldwide.

Join the Study

Financial Support

We gratefully acknowledge the financial support of the work for the EMBRACE III Triplet studies at the Vienna and Visakhapatnam study offices by Elekta (REWIND, IMPACT and PROMISE) and Varian, a Siemens Healthineers Company (IMPACT).

ElektaVarian, a Siemens Healthineers Company

Main Study Office

Medical University of Vienna

Coordinating Study Office - IMPACT

Tata Memorial Centre - Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam